Modulating neuroinflammation in COVID-19 patients with obsessive-compulsive disorder.
J Psychiatr Res
; 149: 367-373, 2022 05.
Article
in English
| MEDLINE | ID: covidwho-1517365
ABSTRACT
Exacerbation of symptoms of obsessive-compulsive disorder (OCD) during COVID-19 or new onset of the OCD symptoms resulting from COVID-19 infection is an understudied area of research. It is possible that increased proinflammatory immune status is associated with the onset of obsessive-compulsive symptoms in patients with COVID-19 and that targeted anti-inflammatory treatments for COVID-19 infection can mitigate the new onset of Obsessive-Compulsive (OC) spectrum symptoms. In this review, we cover OCD pathogenesis as related to COVID-19, summarize the impact of cytokines on behavior, and suggest that anti-cytokine treatments can help mitigate post-COVID-19 and new onset of the OC symptoms.
Keywords
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
COVID-19
/
Obsessive-Compulsive Disorder
Type of study:
Diagnostic study
Topics:
Long Covid
Limits:
Humans
Language:
English
Journal:
J Psychiatr Res
Year:
2022
Document Type:
Article
Affiliation country:
J.jpsychires.2021.11.025
Similar
MEDLINE
...
LILACS
LIS